ARCHIVES

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010

NCI-Approved Clinical Trials

March 31, 2006

Rall, FDA Chief On AACR Panel

April 27, 1979

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975